滋养外胚层活检相关的母儿结局
该观察性队列研究在大学附属生殖中心比较了经滋养外胚层活检行胚胎植入前遗传学检测(PGT)的IVF妊娠(n=177)与未活检IVF妊娠(n=180)的母儿结局,发现IVF+PGT组子痫前期风险显著升高(10.5% vs 4.1%,aOR=3.02,95%CI 1.10–8.29),限制为单胎活产后该趋势仍持续;作者认为这是迄今规模最大、控制最全面的相关研究,鉴于PGT使用增加,需进一步研究。
要点
- IVF+PGT组子痫前期发生率10.5%,高于未活检IVF组的4.1%(aOR=3.02,95%CI 1.10–8.29)。
- 前置胎盘发生率IVF+PGT组为5.8%,未活检IVF组为1.4%(aOR=4.56,95%CI 0.93–22.44)。
- 两组新生儿出生体重、早产、低出生体重、NICU入住、新生儿疾病及出生缺陷无显著差异。
核心结论
- 这是迄今规模最大、控制最全面的滋养外胚层活检后母儿结局研究,发现活检与子痫前期风险约三倍升高相关(aOR=3.02),鉴于PGT使用增加,需进一步研究。
研究设计与样本
- 观察性队列研究,在大学附属生殖中心纳入经IVF+PGT活产妊娠177例与未活检IVF活产妊娠180例,无干预。
主要发现
- IVF+PGT组子痫前期发生率10.5%,未活检IVF组4.1%(aOR=3.02;95%CI 1.10–8.29)。
- IVF+PGT组前置胎盘发生率5.8%,未活检IVF组1.4%(aOR=4.56;95%CI 0.93–22.44)。
- 两组妊娠期糖尿病、未足月胎膜早破及产后出血发生率相似。
- 两组新生儿分娩孕周、早产率、低出生体重、NICU入住、新生儿疾病及出生缺陷无显著差异。
- 所有趋势(包括IVF+PGT组子痫前期风险显著升高)在仅分析单胎活产后仍持续。
局限性
- 原文结论指出鉴于PGT使用增加,需进一步研究(further investigation is warranted)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether pregnancies achieved with trophectoderm biopsy for preimplantation genetic testing (PGT) have different risks of adverse obstetric and neonatal outcomes compared with pregnancies achieved with IVF without biopsy. DESIGN: Observational cohort. SETTING: University-affiliated fertility center. PATIENT(S): Pregnancies achieved via IVF with PGT (n = 177) and IVF without PGT (n = 180) that resulted in a live birth. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Maternal outcomes including preeclampsia and placenta previa and neonatal outcomes including birth weight and birth defects. RESULT(S): There was a statistically significant increase in the risk of preeclampsia among IVF+PGT pregnancies compared with IVF without PGT pregnancies, with an incidence of 10.5% versus 4.1% (adjusted odds ratio [aOR] = 3.02; 95% confidence interval [95% CI], 1.10, 8.29). The incidence of placenta previa was 5.8% in IVF+PGT pregnancies versus 1.4% in IVF without PGT pregnancies (aOR = 4.56; 95% CI, 0.93, 22.44). Similar incidences of gestational diabetes, preterm premature rupture of membranes, and postpartum hemorrhage were observed. IVF+PGT and IVF without PGT neonates did not have a significantly different gestational age at delivery or rate of preterm birth, low birth weight, neonatal intensive care unit admission, neonatal morbidities, or birth defects. All trends, including the significantly increased risk of preeclampsia in IVF+PGT pregnancies, persisted upon stratification of analysis to only singleton live births. CONCLUSION(S): To date, this is the largest and most extensively controlled study examining maternal and neonatal outcomes after trophectoderm biopsy. There was a statistically significant three-fold increase in the odds of preeclampsia associated with trophectoderm biopsy. Given the rise in PGT use, further investigation is warranted.
引用
- Zhang WY, von Versen-Höynck F, Kapphahn KI, et al. Maternal and neonatal outcomes associated with trophectoderm biopsy. Fertil Steril. 2019. PMID: 31103283. doi:10.1016/j.fertnstert.2019.03.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。